Development of a New Class of Broad-Stage Antimalarial Agents

2017年，90个不同国家发生了近2.2亿例疟疾病例，导致43.5万人死亡，不幸的是，所有疟疾死亡中有65-70%是5岁以下儿童。过去4年来，在减少全球疟疾病例方面没有取得重大进展，对新的和更好的治疗方法的需求仍然十分迫切。在这个研发计划中，我们将开发新的和更安全的药物来治疗耐药疟疾。

In 2017, there were almost 220 million cases of malaria across 90 different countries, associated with 435,000 deaths, and with 65-70% of all malaria deaths tragically being children under the age of 5 years old. No significant progress in reducing global malaria cases has been made over the last 4 years and the need for new and better treatments remains dire. In this research and development plan, we will develop novel and safer drugs for the treatment of drug resistant malaria.